A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence - a ...

Early-stage gastric cancer can be assessed more accurately using a new liquid biopsy tool that predicts lymph node metastasis ...

Recent polling shows oncologists changing inclination in treatment for mHSPC based on tolerability profiles.

Dr. Jeff Jones, a former U.S. Navy aviator and NASA physician, was diagnosed with prostate cancer after a routine checkup detected a rising prostate-specific antigen (PSA) level, which can signal ...

Department of Radiology, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China Introduction: This study was conducted to evaluate any association between extraprostatic extension (EPE) grade with the ...

PSMA-PET is a relatively new imaging technique that shows great potential for diagnosis and treatment assessment in prostate cancer patients. Existing studies in the literature involving PSMA-PET ...

Chemotherapy remains vital in metastatic castration-resistant prostate cancer (mCRPC) despite androgen receptor pathway inhibitors (ARPIs), poly (ADP-ribose) polymerase (PARP) inhibitors, and ...

Justin Stebbing does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Prostate cancer, a common malignancy in men, can rarely spread to the skin, a condition known as cutaneous metastasis. These ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...